Showing results (711-720 of 793) with videos related to

Sort By:
Pageof 80
ESMO Open|September 9, 2022
Phase Ib study of eprenetapopt (APR-246) in combination with pembrolizumab in patients with advanced or metastatic solid tumorsH Park, G I Shapiro, X Gao, et al.
Molecular Microbiology|March 11, 2004
SCP1, a 356,023 bp linear plasmid adapted to the ecology and developmental biology of its host, Streptomyces coelicolor A3(2)S D Bentley, S Brown, L D Murphy, et al.
Homo : Internationale Zeitschrift Fur Die Vergleichende Forschung Am Menschen|July 16, 2010
Growth variation, final height and secular trend. Proceedings of the 17th Aschauer Soiree, 7th November 2009M Hermanussen, E Godina, F J Rühli, et al.
Resuscitation|April 5, 2017
Out of hospital cardiac arrest survivors with inconclusive coronary angiogram: Impact of cardiovascular magnetic resonance on clinical management and decision-makingA Baritussio, A Zorzi, A Ghosh Dastidar, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
The BR-body proteome contains a complex network of protein-protein and protein-RNA interactionsV Nandana, I W Rathnayaka-Mudiyanselage, N S Muthunayak, et al.
Tissue Engineering. Part C, Methods|February 18, 2024
Novel Sheep Model to Assess Critical-Sized Bone Regeneration with Periosteum for In Vivo BioreactorsYohaann A Ghosh, Hai Xin, D S Abdullah Al Maruf, et al.
Journal of Dental Research|December 1, 2025
Extracellular Particles to Track Cancer Biomarkers from Tissue to BiofluidsK T Nguyen, J Xia, C Chang, et al.
Journal of Environmental Science and Health. Part A, Toxic/Hazardous Substances & Environmental Engineering|October 24, 2007
Current knowledge on the distribution of arsenic in groundwater in five states of IndiaR Nickson, C Sengupta, P Mitra, et al.
Hepatology (Baltimore, Md.)|June 25, 2016
Gut microbiota drive the development of neuroinflammatory response in cirrhosis in miceDae Joong Kang, Naga S Betrapally, Siddhartha A Ghosh, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Integration of genomic aberrations to predict clinical outcomes for patients with gastroesophageal adenocarcinoma receiving neoadjuvant chemotherapyE C Smyth, D Watson, M P Castro, et al.
Pageof 80